Scisparc adopts limited duration shareholder rights plan

Tel aviv, israel, nov. 28, 2023 (globe newswire) -- scisparc ltd. (nasdaq: sprc) ("company" or "scisparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that its board of directors (the “board”) has unanimously adopted a limited duration shareholder rights plan (the "rights plan"), effective immediately.
SPRC Ratings Summary
SPRC Quant Ranking